Literature DB >> 7835430

Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP.

P Peraldi1, M Frödin, J V Barnier, V Calleja, J C Scimeca, C Filloux, G Calothy, E Van Obberghen.   

Abstract

In PC12 cells, cAMP stimulates the MAP kinase pathway by an unknown mechanism. Firstly, we examined the role of calcium ion mobilization and of protein kinase C in cAMP-stimulated MAP kinase activation. We show that cAMP stimulates p44mapk independently of these events. Secondly, we studied the role of B-Raf in this process. We observed that NGF, PMA and cAMP induce the phosphorylation of B-Raf as well as an upward shift in its electrophoretic mobility. We show that B-Raf is activated following NGF and PMA treatment of PC12 cells, and that it can phosphorylate and activate MEK-1. However, cAMP inhibits B-Raf autokinase activity as well as its ability to phosphorylate and activate MEK-1. This inhibition is likely to be due to a direct effect since we found that PKA phosphorylates B-Raf in vitro. Further, we show that B-Raf binds to p21ras, but more important, this binding to p21ras is virtually abolished with B-Raf from PC12 cells treated with CPT-cAMP. Hence, these data indicate that the PKA-mediated phosphorylation of B-Raf hampers its interaction with p21ras, which is responsible for the PKA-mediated decrease in B-Raf activity. Finally, our work suggests that in PC12 cells, cAMP stimulates MAP kinase through the activation of an unidentified MEK kinase and/or the inhibition of a MEK phosphatase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7835430     DOI: 10.1016/0014-5793(94)01376-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

2.  FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2.

Authors:  Olivier E Pardo; Claudia Wellbrock; Umme K Khanzada; Muriel Aubert; Imanol Arozarena; Sally Davidson; Frances Bowen; Peter J Parker; V V Filonenko; Ivan T Gout; Neil Sebire; Richard Marais; Julian Downward; Michael J Seckl
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

3.  Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.

Authors:  V Antonelli; F Bernasconi; Y H Wong; L Vallar
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

4.  Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.

Authors:  Hyun-Soo Kim; Sun Ho Lee; Kyu Yeoun Won; Gou Young Kim; Yong-Koo Park; Youn Wha Kim
Journal:  Virchows Arch       Date:  2011-11-20       Impact factor: 4.064

5.  Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells.

Authors:  P Erhardt; J Troppmair; U R Rapp; G M Cooper
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

6.  Raf-1 kinase inhibitory protein expression in thyroid carcinomas.

Authors:  Hyun-Soo Kim; Gou Young Kim; Sung-Jig Lim; Youn Wha Kim
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

7.  The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes.

Authors:  T B Shea; C M Cressman
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

8.  Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

Authors:  E Némoz-Gaillard; M Cordier-Bussat; C Filloux; J C Cuber; E Van Obberghen; J A Chayvialle; J Abello
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

9.  Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.

Authors:  C Liebmann; A Graness; B Ludwig; A Adomeit; A Boehmer; F D Boehmer; B Nürnberg; R Wetzker
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation.

Authors:  Yanping Li; Maho Takahashi; Philip J S Stork
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.